CVS to pay $5 million to settle deceptive pricing case
CVS Caremark Corp. has agreed to pay $5 million to settle charges that it misrepresented the prices of some Medicare Part D drugs.

CVS Caremark Buys Medicare Part D Biz
Health Net Inc. said Monday it will sell its Medicare Part D stand-alone prescription drug business to CVS Caremark for $160 million. Health Net said ...